Cargando…
Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway
INTRODUCTION: Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive malignant tumors. Eukaryotic translation initiation factors 3B (EIF3B) is considered to influence tumor proliferation, invasion, apoptosis and cell cycle, which act together to promote the progression of tumors. Ho...
Autores principales: | Xu, Fengkai, Xu, Cheng-Zhi, Gu, Jie, Liu, Xiaoming, Liu, Ronghua, Huang, Enyu, Yuan, Yunfeng, Zhao, Guangyin, Jiang, Jiahao, Xu, Chen, Chu, Yiwei, Lu, Chunlai, Ge, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190032/ https://www.ncbi.nlm.nih.gov/pubmed/27270324 http://dx.doi.org/10.18632/oncotarget.9726 |
Ejemplares similares
-
Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients
por: Xu, Fengkai, et al.
Publicado: (2018) -
Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma
por: Li, Yin, et al.
Publicado: (2021) -
Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma
por: Xu, Fengkai, et al.
Publicado: (2020) -
Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway
por: Xu, Fengkai, et al.
Publicado: (2019) -
TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma
por: Xu, Fengkai, et al.
Publicado: (2019)